Cases with Castle: Learn how MyPath Melanoma can help differentiate between different diagnoses

MyPath Melanoma Test for Atypical Lesions: Dr. Dmitriy Timerman on Diagnosis & Surgical MarginsПодробнее

Confirming Difficult Diagnoses in Melanocytic Lesions with MyPath MelanomaПодробнее

How MyPath Melanoma Test Aids in Diagnosing Challenging Skin Lesions: Dr. Abel Jarrell ExplainsПодробнее

When to Use MyPath Melanoma: Dr. Neil Fernandes on Managing Ambiguous Skin LesionsПодробнее

Cases with Castle: A case study webinar on ambiguous melanocytic lesions - Dr. Alexander WitkowskiПодробнее

How MyPath Melanoma Test Results Guide Surgical DecisionsПодробнее

How MyPath Melanoma Resolves Uncertainty in Diagnosing Skin LesionsПодробнее

How MyPath Melanoma Helps Diagnose Challenging Melanocytic LesionsПодробнее

When to Use MyPath Melanoma: Solving Ambiguity in Diagnosing Pigmented LesionsПодробнее

Cases with Castle: A melanoma case study series presented by Dr. Angela WingfieldПодробнее

Dr. Dmitriy Timerman on Diagnosing Atypical Skin Lesions & Surgical Precision with MyPath MelanomaПодробнее

Cases with Castle Biosciences - Barry White, M.D.Подробнее

Cases with Castle: Resolving diagnostic ambiguity using GEP testing - Dr. Clay CockerellПодробнее

Streamlining Diagnosis: Dr. Neil Fernandes on the MyPath Melanoma Ordering ProcessПодробнее

The DecisionDx®-Melanoma Test Complements Current Melanoma StagingПодробнее

How MyPath Melanoma Brings Clarity to Patients: Dr. Shannon Trotter ExplainsПодробнее

How MyPath Melanoma Results Guide Treatment and Surgical DecisionsПодробнее

When to Use MyPath Melanoma: Dr. Shannon Trotter on Diagnosing Ambiguous Skin LesionsПодробнее

How MyPath Melanoma Test Helps Avoid Large Surgeries:Подробнее